[Skip to Navigation]
Sign In
Figure 1.  Flowcharts of Participant Inclusion in the Cohort Analyses and Study Inclusion in the Meta-analysis
Flowcharts of Participant Inclusion in the Cohort Analyses and Study Inclusion in the Meta-analysis

The median (IQR) follow-up durations were 12.9 (12.2-13.8) years in the Whitehall II study (A), 5.0 (3.0-5.0) years in the Health and Retirement Study (B), and 10.7 (7.5-14.3) years in Framingham Heart Study Offspring cohort (C). D, Search strategy used for the meta-analysis. FFQ indicates food frequency questionnaire.

Figure 2.  Meta-analysis of Multivariable-Adjusted Hazard Ratio (HR) and 95% CI for Incident Dementia Comparing the Highest vs Lowest Tertile of Mediterranean–Dietary Approaches to Stop Hypertension (DASH) Intervention for Neurodegenerative Delay (MIND) Diet Score
Meta-analysis of Multivariable-Adjusted Hazard Ratio (HR) and 95% CI for Incident Dementia Comparing the Highest vs Lowest Tertile of Mediterranean–Dietary Approaches to Stop Hypertension (DASH) Intervention for Neurodegenerative Delay (MIND) Diet Score

HR below 1.00 indicates a lower risk of dementia. We used random-effects models to pool the risk estimates comparing highest vs lowest MIND diet tertiles. CHAP indicates Chicago Health and Aging Project26; FOS, Framingham Heart Study Offspring cohort; HRS, Health and Retirement Study; MAP, Memory and Aging Project26; RS, Rotterdam Study21; 3C, Three-City Study28; UKB, UK Biobank27; WHI-MS, Women’s Health Initiative Memory Study26; WII, Whitehall II study.

Table 1.  Baseline Characteristics of Participants in the Whitehall II Study, the Health and Retirement Study, and the Framingham Offspring Cohort
Baseline Characteristics of Participants in the Whitehall II Study, the Health and Retirement Study, and the Framingham Offspring Cohort
Table 2.  Multivariable-Adjusted Hazard Ratios (HRs) and 95% CIs for Incident Dementia According to Tertiles of Mediterranean–Dietary Approaches to Stop Hypertension (DASH) Intervention for Neurodegenerative Delay (MIND) Diet Scorea
Multivariable-Adjusted Hazard Ratios (HRs) and 95% CIs for Incident Dementia According to Tertiles of Mediterranean–Dietary Approaches to Stop Hypertension (DASH) Intervention for Neurodegenerative Delay (MIND) Diet Scorea
1.
Livingston  G, Huntley  J, Sommerlad  A,  et al.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.   Lancet. 2020;396(10248):413-446. doi:10.1016/S0140-6736(20)30367-6PubMedGoogle ScholarCrossref
2.
GBD 2019 Dementia Forecasting Collaborators.  Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.   Lancet Public Health. 2022;7(2):e105-e125. doi:10.1016/S2468-2667(21)00249-8Google ScholarCrossref
3.
Prince  M, Wimo  A, Guerchet  M, Ali  GC, Wu  YT, Prina  M. World Alzheimer Report 2015—the global impact of dementia: an analysis of prevalence, incidence, cost and trends. Accessed May 16, 2022. https://www.alzint.org/u/WorldAlzheimerReport2015.pdf
4.
Baumgart  M, Snyder  HM, Carrillo  MC, Fazio  S, Kim  H, Johns  H.  Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective.   Alzheimers Dement. 2015;11(6):718-726. doi:10.1016/j.jalz.2015.05.016PubMedGoogle ScholarCrossref
5.
Morris  MC.  Nutrition and risk of dementia: overview and methodological issues.   Ann N Y Acad Sci. 2016;1367(1):31-37. doi:10.1111/nyas.13047PubMedGoogle ScholarCrossref
6.
Cao  L, Tan  L, Wang  HF,  et al.  Dietary patterns and risk of dementia: a systematic review and meta-analysis of cohort studies.   Mol Neurobiol. 2016;53(9):6144-6154. doi:10.1007/s12035-015-9516-4PubMedGoogle ScholarCrossref
7.
van de Rest  O, Berendsen  AA, Haveman-Nies  A, de Groot  LC.  Dietary patterns, cognitive decline, and dementia: a systematic review.   Adv Nutr. 2015;6(2):154-168. doi:10.3945/an.114.007617PubMedGoogle ScholarCrossref
8.
Liu  YH, Gao  X, Na  M, Kris-Etherton  PM, Mitchell  DC, Jensen  GL.  Dietary pattern, diet quality, and dementia: a systematic review and meta-analysis of prospective cohort studies.   J Alzheimers Dis. 2020;78(1):151-168. doi:10.3233/JAD-200499PubMedGoogle ScholarCrossref
9.
Yuan  C, Chen  H, Wang  Y, Schneider  JA, Willett  WC, Morris  MC.  Dietary carotenoids related to risk of incident Alzheimer dementia (AD) and brain AD neuropathology: a community-based cohort of older adults.   Am J Clin Nutr. 2021;113(1):200-208. doi:10.1093/ajcn/nqaa303PubMedGoogle ScholarCrossref
10.
Commenges  D, Scotet  V, Renaud  S, Jacqmin-Gadda  H, Barberger-Gateau  P, Dartigues  JF.  Intake of flavonoids and risk of dementia.   Eur J Epidemiol. 2000;16(4):357-363. doi:10.1023/A:1007614613771PubMedGoogle ScholarCrossref
11.
Cheng  N, Bell  L, Lamport  DJ, Williams  CM.  Dietary flavonoids and human cognition: a meta-analysis.   Mol Nutr Food Res. 2022;66(21):e2100976. doi:10.1002/mnfr.202100976Google ScholarCrossref
12.
Crichton  GE, Bryan  J, Murphy  KJ.  Dietary antioxidants, cognitive function and dementia: a systematic review.   Plant Foods Hum Nutr. 2013;68(3):279-292. doi:10.1007/s11130-013-0370-0PubMedGoogle ScholarCrossref
13.
Wu  S, Ding  Y, Wu  F, Li  R, Hou  J, Mao  P.  Omega-3 fatty acids intake and risks of dementia and Alzheimer’s disease: a meta-analysis.   Neurosci Biobehav Rev. 2015;48:1-9. doi:10.1016/j.neubiorev.2014.11.008PubMedGoogle ScholarCrossref
14.
Bakre  AT, Chen  R, Khutan  R,  et al.  Association between fish consumption and risk of dementia: a new study from China and a systematic literature review and meta-analysis.   Public Health Nutr. 2018;21(10):1921-1932. doi:10.1017/S136898001800037XPubMedGoogle ScholarCrossref
15.
Ran  LS, Liu  WH, Fang  YY,  et al.  Alcohol, coffee, and tea intake and the risk of cognitive deficits: a dose-response meta-analysis.   Epidemiol Psychiatr Sci. 2021;30:e13. doi:10.1017/S2045796020001183PubMedGoogle ScholarCrossref
16.
Akbaraly  TN, Singh-Manoux  A, Dugravot  A, Brunner  EJ, Kivimäki  M, Sabia  S.  Association of midlife diet with subsequent risk for dementia.   JAMA. 2019;321(10):957-968. doi:10.1001/jama.2019.1432PubMedGoogle ScholarCrossref
17.
Morris  MC, Tangney  CC, Wang  Y,  et al.  MIND diet slows cognitive decline with aging.   Alzheimers Dement. 2015;11(9):1015-1022. doi:10.1016/j.jalz.2015.04.011PubMedGoogle ScholarCrossref
18.
Morris  MC, Tangney  CC, Wang  Y, Sacks  FM, Bennett  DA, Aggarwal  NT.  MIND diet associated with reduced incidence of Alzheimer’s disease.   Alzheimers Dement. 2015;11(9):1007-1014. doi:10.1016/j.jalz.2014.11.009PubMedGoogle ScholarCrossref
19.
Berendsen  AM, Kang  JH, Feskens  EJM, de Groot  CPGM, Grodstein  F, van de Rest  O.  Association of long-term adherence to the MIND diet with cognitive function and cognitive decline in American women.   J Nutr Health Aging. 2018;22(2):222-229. doi:10.1007/s12603-017-0909-0PubMedGoogle ScholarCrossref
20.
Hosking  DE, Eramudugolla  R, Cherbuin  N, Anstey  KJ.  MIND not Mediterranean diet related to 12-year incidence of cognitive impairment in an Australian longitudinal cohort study.   Alzheimers Dement. 2019;15(4):581-589. doi:10.1016/j.jalz.2018.12.011PubMedGoogle ScholarCrossref
21.
de Crom  TOE, Mooldijk  SS, Ikram  MK, Ikram  MA, Voortman  T.  MIND diet and the risk of dementia: a population-based study.   Alzheimers Res Ther. 2022;14(1):8. doi:10.1186/s13195-022-00957-1PubMedGoogle ScholarCrossref
22.
Gómez-Pinilla  F.  Brain foods: the effects of nutrients on brain function.   Nat Rev Neurosci. 2008;9(7):568-578. doi:10.1038/nrn2421PubMedGoogle ScholarCrossref
23.
Marmot  M, Brunner  E.  Cohort profile: the Whitehall II study.   Int J Epidemiol. 2005;34(2):251-256. doi:10.1093/ije/dyh372PubMedGoogle ScholarCrossref
24.
Sonnega  A, Faul  JD, Ofstedal  MB, Langa  KM, Phillips  JWR, Weir  DR.  Cohort profile: the Health and Retirement Study (HRS).   Int J Epidemiol. 2014;43(2):576-585. doi:10.1093/ije/dyu067PubMedGoogle ScholarCrossref
25.
Tsao  CW, Vasan  RS.  Cohort profile: the Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology.   Int J Epidemiol. 2015;44(6):1800-1813. doi:10.1093/ije/dyv337PubMedGoogle ScholarCrossref
26.
Vu  THT, Beck  T, Bennett  DA,  et al.  Adherence to MIND diet, genetic susceptibility, and incident dementia in 3 US cohorts.   Nutrients. 2022;14(13):2759. doi:10.3390/nu14132759PubMedGoogle ScholarCrossref
27.
Zhang  J, Cao  X, Li  X,  et al.  Associations of midlife diet quality with incident dementia and brain structure: findings from the UK Biobank Study.   medRxiv. Preprint posted online May 2, 2022. doi:10.1101/2022.05.06.22274696Google Scholar
28.
Thomas  A, Lefèvre-Arbogast  S, Féart  C,  et al.  Association of a MIND diet with brain structure and dementia in a French population.   J Prev Alzheimers Dis. 2022;9(4):655-664. doi:10.14283/jpad.2022.67PubMedGoogle ScholarCrossref
29.
Brunner  E, Stallone  D, Juneja  M, Bingham  S, Marmot  M.  Dietary assessment in Whitehall II: comparison of 7 d diet diary and food-frequency questionnaire and validity against biomarkers.   Br J Nutr. 2001;86(3):405-414. doi:10.1079/BJN2001414PubMedGoogle ScholarCrossref
30.
Juster  FT, Suzman  R.  An overview of the Health and Retirement Study.   J Hum Resour. 1995;30:S7-S56. doi:10.2307/146277Google ScholarCrossref
31.
Bishop  NJ, Wang  K.  Food insecurity, comorbidity, and mobility limitations among older US adults: findings from the Health and Retirement Study and Health Care and Nutrition Study.   Prev Med. 2018;114:180-187. doi:10.1016/j.ypmed.2018.07.001PubMedGoogle ScholarCrossref
32.
Satizabal  CL, Beiser  AS, Chouraki  V, Chêne  G, Dufouil  C, Seshadri  S.  Incidence of dementia over 3 decades in the Framingham Heart Study.   N Engl J Med. 2016;374(6):523-532. doi:10.1056/NEJMoa1504327PubMedGoogle ScholarCrossref
33.
Pase  MP, Himali  JJ, Beiser  AS,  et al.  Sugar- and artificially sweetened beverages and the risks of incident stroke and dementia: a prospective cohort study.   Stroke. 2017;48(5):1139-1146. doi:10.1161/STROKEAHA.116.016027PubMedGoogle ScholarCrossref
34.
von Elm  E, Altman  DG, Egger  M, Pocock  SJ, Gøtzsche  PC, Vandenbroucke  JP; STROBE Initiative.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.   Ann Intern Med. 2007;147(8):573-577. doi:10.7326/0003-4819-147-8-200710160-00010PubMedGoogle ScholarCrossref
35.
Willett  WC, Sampson  L, Stampfer  MJ,  et al.  Reproducibility and validity of a semiquantitative food frequency questionnaire.   Am J Epidemiol. 1985;122(1):51-65. doi:10.1093/oxfordjournals.aje.a114086PubMedGoogle ScholarCrossref
36.
Yuan  C, Spiegelman  D, Rimm  EB,  et al.  Validity of a dietary questionnaire assessed by comparison with multiple weighed dietary records or 24-hour recalls.   Am J Epidemiol. 2017;185(7):570-584. doi:10.1093/aje/kww104PubMedGoogle ScholarCrossref
37.
Yuan  C, Spiegelman  D, Rimm  EB,  et al.  Relative validity of nutrient intakes assessed by questionnaire, 24-hour recalls, and diet records as compared with urinary recovery and plasma concentration biomarkers: findings for women.   Am J Epidemiol. 2018;187(5):1051-1063. doi:10.1093/aje/kwx328PubMedGoogle ScholarCrossref
38.
Al-Shaar  L, Yuan  C, Rosner  B,  et al.  Reproducibility and validity of a semiquantitative food frequency questionnaire in men assessed by multiple methods.   Am J Epidemiol. 2021;190(6):1122-1132. doi:10.1093/aje/kwaa280PubMedGoogle ScholarCrossref
39.
Yue  Y, Yuan  C, Wang  DD,  et al.  Reproducibility and validity of diet quality scores derived from food-frequency questionnaires.   Am J Clin Nutr. 2022;115(3):843-853. doi:10.1093/ajcn/nqab368PubMedGoogle ScholarCrossref
40.
Crimmins  EM, Kim  JK, Langa  KM, Weir  DR.  Assessment of cognition using surveys and neuropsychological assessment: the Health and Retirement Study and the Aging, Demographics, and Memory Study.   J Gerontol B Psychol Sci Soc Sci. 2011;66 suppl 1(suppl 1):i162-i171. doi:10.1093/geronb/gbr048Google ScholarCrossref
41.
Moher  D, Liberati  A, Tetzlaff  J, Altman  DG; PRISMA Group.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.   PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097PubMedGoogle ScholarCrossref
42.
Mediterranean–Dietary Approaches to Stop Hypertension (MIND) diet and risk of dementia: meta-analysis of cohort studies. INPLASY:INPLASY202270127. Published online July 31, 2022. https://inplasy.com/inplasy-2022-7-0127/
43.
Schwarzer  G.  meta: an R package for meta-analysis.   R News. 2007;7(3):40-45.Google Scholar
44.
Higgins  JPT, Thomas  J, Chandler  J,  et al, eds.  Cochrane Handbook for Systematic Reviews of Interventions. 2nd ed. John Wiley & Sons; 2019.
45.
Riley  RD, Lambert  PC, Abo-Zaid  G.  Meta-analysis of individual participant data: rationale, conduct, and reporting.   BMJ. 2010;340:c221. doi:10.1136/bmj.c221PubMedGoogle ScholarCrossref
46.
Byers  AL, Yaffe  K.  Depression and risk of developing dementia.   Nat Rev Neurol. 2011;7(6):323-331. doi:10.1038/nrneurol.2011.60PubMedGoogle ScholarCrossref
47.
VanderWeele  TJ, Ding  P.  Sensitivity analysis in observational research: introducing the E-value.   Ann Intern Med. 2017;167(4):268-274. doi:10.7326/M16-2607PubMedGoogle ScholarCrossref
48.
Schafer  JL.  Multiple imputation: a primer.   Stat Methods Med Res. 1999;8(1):3-15. doi:10.1177/096228029900800102PubMedGoogle ScholarCrossref
49.
Chêne  G, Thompson  SG.  Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form.   Am J Epidemiol. 1996;144(6):610-621. doi:10.1093/oxfordjournals.aje.a008971PubMedGoogle ScholarCrossref
50.
Liu  X, Morris  MC, Dhana  K,  et al.  Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) study: rationale, design and baseline characteristics of a randomized control trial of the MIND diet on cognitive decline.   Contemp Clin Trials. 2021;102:106270. doi:10.1016/j.cct.2021.106270PubMedGoogle ScholarCrossref
51.
McCleery  J, Abraham  RP, Denton  DA,  et al.  Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.   Cochrane Database Syst Rev. 2018;11(11):CD011905. doi:10.1002/14651858.CD011905.pub2PubMedGoogle ScholarCrossref
52.
de la Monte  SM, Neusner  A, Chu  J, Lawton  M.  Epidemiological trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer’s disease, diabetes mellitus, and non-alcoholic steatohepatitis.   J Alzheimers Dis. 2009;17(3):519-529. doi:10.3233/JAD-2009-1070PubMedGoogle ScholarCrossref
Original Investigation
May 3, 2023

Association of the Mediterranean Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) Diet With the Risk of Dementia

Author Affiliations
  • 1School of Public Health, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
  • 2Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois
  • 3Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois
  • 4Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, UT Health San Antonio, San Antonio, Texas
  • 5Department of Neurology, Boston University School of Medicine, Boston, Massachusetts
  • 6Framingham Heart Study, Framingham, Massachusetts
  • 7State Key Laboratory of Genetic Engineering, Human Phenome Institute, and School of Life Sciences, Fudan University, Shanghai, China
  • 8Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts
JAMA Psychiatry. 2023;80(6):630-638. doi:10.1001/jamapsychiatry.2023.0800
Key Points

Question  Is adherence to the Mediterranean–Dietary Approaches to Stop Hypertension (DASH) Intervention for Neurodegenerative Delay (MIND) diet associated with the risk of dementia?

Findings  In this investigation of 3 prospective cohort studies including 18 136 participants and a meta-analysis including 224 049 participants, adherence to the MIND diet was associated with a lower risk of incident dementia in middle-aged and older adults. The highest adherence was associated with approximately 17% lower risk of dementia compared with the lowest adherence.

Meaning  The MIND diet may potentially reduce dementia risk, but further investigations are needed in different populations.

Abstract

Importance  Dementia threatens the well-being of older adults, making efforts toward prevention of great importance.

Objective  To evaluate the association of the Mediterranean–Dietary Approaches to Stop Hypertension (DASH) Intervention for Neurodegenerative Delay (MIND) diet with the risk of dementia in 3 prospective studies and a meta-analysis.

Design, Setting, and Participants  Cohort analyses included the Whitehall II study (WII), the Health and Retirement Study (HRS), and the Framingham Heart Study Offspring cohort (FOS), and the meta-analysis included 11 cohort studies. Participants were middle-aged and older women and men from WII in 2002 to 2004, HRS in 2013, and FOS in 1998 to 2001 without dementia at the study baseline. Data were analyzed from May 25 to September 1, 2022.

Exposures  MIND diet score was measured using food frequency questionnaires, and scores ranged from 0 to 15, with a higher score indicating higher adherence to the MIND diet.

Main Outcome and Measures  Incident all-cause dementia, with cohort-specific definitions.

Results  Included in this study were 8358 participants (mean [SD] age, 62.2 [6.0] years; 5777 male [69.1%]) from WII, 6758 participants (mean [SD] age, 66.5 [10.4] years; 3965 female [58.7%]) from HRS, and 3020 participants (mean [SD] age, 64.2 [9.1] years; 1648 female [54.6%]) from FOS. The mean (SD) baseline MIND diet score was 8.3 (1.4) in WII, 7.1 (1.9) in HRS, and 8.1 (1.6) in FOS. Over 166 516 person-years, a total of 775 participants (220 in WII, 338 in HRS, and 217 in FOS) developed incident dementia. In the multivariable-adjusted Cox proportional hazard model, higher MIND diet score was associated with lower risk of dementia (pooled hazard ratio [HR] for every 3-point increment, 0.83; 95% CI, 0.72-0.95; P for trend = .01; I2 = 0%). The associations were consistently observed in subgroups defined by sex, age, smoking status, and body mass index. In the meta-analysis of 11 cohort studies with 224 049 participants (5279 incident dementia cases), the highest tertile of MIND diet score was associated with lower risk of dementia compared with the lowest tertile (pooled HR, 0.83; 95% CI, 0.76-0.90; I2 = 35%).

Conclusions and Relevance  Results suggest that adherence to the MIND diet was associated with lower risk of incident dementia in middle-aged and older adults. Further studies are warranted to develop and refine the specific MIND diet for different populations.

Introduction

All-cause dementia poses substantial burdens on health care systems and threatens the well-being of older adults,1,2 and lack of effective treatments makes its prevention of great importance.1,3 Among numerous potential risk factors,1,4 dietary factors have generated major interest,5-8 including specific nutrients,9-13 food groups,14,15 and dietary patterns.6,8,16

Devised by Morris et al,17 the Mediterranean–Dietary Approaches to Stop Hypertension (DASH) Intervention for Neurodegenerative Delay (MIND) diet has been associated with lower risk of Alzheimer disease (AD)18 and slower cognitive decline.17 The MIND diet emphasizes natural plant-based foods, limited intake of animal foods and foods high in saturated fat, and uniquely encourages consumption of berries and green leafy vegetables17 rich in vitamins and antioxidants. Previous studies have assessed its association with cognitive function and decline,17,19,20 but only a few studies have examined its association with all-cause dementia or AD, with inconclusive results. In the Memory and Aging Project (MAP), which included 923 participants for a mean follow-up of 4.5 years, higher adherence to the MIND diet was associated with lower risk of AD.18 In the Rotterdam Study,21 the association of the MIND diet with incident dementia was statistically significant in the first 7 years of follow-up but became nonsignificant afterward. In aggregate, several constituents in the MIND diet have been suggested to be beneficial for cognitive health through the promotion of cardiovascular health or independent pathways directly linked to brain health,22 but the role of the MIND diet in dementia prevention remains inconclusive.

In the current study, we assessed the associations of adherence to the MIND diet with incident all-cause dementia in 3 cohort studies,23-25 1 from the UK, the Whitehall II study (WII), and 2 from the US, the Health and Retirement Study (HRS) and the Framingham Heart Study Offspring cohort (FOS). Further, we conducted a meta-analysis of 11 cohort studies21,26-28 reported in 5 articles to understand the association of the MIND diet with the risk of dementia.

Methods
Study Population

We leveraged individual-level data from 3 prospective studies.23-25 The WII was aimed at understanding the causes of age-related heterogeneity in health.23 WII enrolled 10 308 civil workers aged 35 to 55 years in 1985 and administered dietary assessments29 at phases 3 (1991-1993), 5 (1997-1999), and 7 (2002-2004).16 The HRS is a nationally representative cohort study of US adults 50 years and older.24,30 In 2013, 8035 HRS participants completed the Health Care and Nutrition Study, a substudy that contains a dietary assessment,31 followed by 3 cognitive assessments in 2014, 2016, and 2018. The Framingham Heart Study is a community-based cohort study commenced in 1948.25 In 1971, children of the original cohort and their spouses formed the FOS cohort. FOS participants completed dietary assessments in examinations 5 (1991-1995), 6 (1995-1998), and 7 (1998-2001) and have undergone continuous surveillance for dementia through 2018.32 All participants provided informed consent before data collection. The WII was approved by University College London Medical School committee, the HRS was approved by University of Michigan institutional review board (IRB), and the FOS was approved by Boston University Medical Center IRB.

In this study, we followed up WII participants from baseline (phase 7, 2002-2004) to 2016, HRS participants from baseline (2013) to 2018, and FOS participants from baseline (examination 7, 1998-2001) to 2018, which was consistent with previous studies.16,33 Thus, all assessments of diet preceded the ascertainment of dementia. We included participants 45 years and older who completed 1 or more valid food frequency questionnaires ([FFQs] defined as total energy intake in 500-4500 kcal). Participants with dementia at baseline or those who developed dementia in the first 2 years of follow-up were excluded (Figure 1A-C) to account, in part, for reverse causality. All participants provided written informed consent in the cohort studies. The current study was approved by IRB of Zhejiang University School of Public Health and followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guidelines34 for reporting observational studies.

MIND Diet Score

Participants were asked how often on average they consumed a specified amount of food in the past year using FFQs.23-25 Despite some cohort-specific modifications, the FFQs in all 3 cohort studies were based on the extensively validated FFQ35-39 devised by Willett and colleagues.35

The primary exposure was the MIND diet score, which consisted of 10 recommended food groups and 5 restricted food groups17 (eTable 1 in Supplement 1). The total score was computed by summing the 15 component scores (range, 0-15), with a higher score indicating higher adherence to the MIND diet. In the WII, which lacks information on olive oil, the original score ranged from 0 to 14 and was rescaled to a range of 0 to 15. We used the mean MIND diet scores for participants with assessments before baseline to reduce measurement error.

Ascertainment of Incident Dementia

The outcome of interest was incident all-cause dementia. The 3 cohort studies had different strategies in identifying incident dementia cases. Briefly, WII ascertained dementia using linkage to health care systems,16 HRS ascertained dementia using a validated algorithm,40 and FOS conducted panel reviews for dementia identification.32 Details are described in eMethods in Supplement 1.

Assessment of Other Covariates

We used questionnaires completed at and before baseline to collect the information on age (5-year groups), sex (male or female), race and ethnicity (White and non-White for WII and Black or African American, Hispanic, White, and Other for HRS), education level (high school diploma or not), occupational class (3 categories available in WII: administrative, professional, and supportive and clerical),16 household income (categorized into quartiles, available in the HRS and FOS), frequency of vigorous physical activity (<1 times per month, 1-4 times per month, or >1 times per week), current smoking status (yes or no), total energy intake, body mass index (BMI) categories (<25.0, 25.0-<30.0, or ≥30.0; calculated as weight in kilograms divided by height in meters squared), depressive symptom (yes or no), hypertension (yes or no), hypercholesterolemia (yes or no, not available in the HRS), diabetes (yes or no), stroke (yes or no), and cardiovascular diseases (yes or no). WII used a merged non-White racial category to protect the privacy of its participants. FOS did not take participant race into account because its racial makeup was predominantly White of European descent. Total energy was calculated from the FFQ concurrent with the MIND score. Alcohol intake was not considered a confounding variable because wine is a component of the MIND diet. Household income was assessed at examination 3 (1983-1987) for FOS participants and in 2014 for HRS participants. The assessments of health conditions are shown in eMethods in Supplement 1.

Meta-analysis

We conducted a meta-analysis using data from the current study and all other published population-based cohort studies reporting the association between the MIND diet and dementia or AD. Following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guidelines,41 we registered the protocol on INPLASY.42 We systematically searched PubMed, Embase, and Web of Science on July 26, 2022, using strategy presented in eTable 2 in Supplement 1 and additionally screened the references of the included articles.

We included cohort studies that assessed the associations of the MIND diet and incident dementia or AD and extracted the name of the first author, publication year, cohort name, country, number of participants, age range at baseline, dietary assessment methods, and dementia ascertainment methods, risk estimates and 95% CIs from the multivariable-adjusted models and included covariates. We used the Newcastle-Ottawa scale to assess the quality of included studies. Two authors (H.C. and L.H.) independently screened the literature, extracted the data, and assessed the risk of bias. Disagreement and discordance were resolved by the third author (Y.H.).

We used random-effect models to pool the risk estimates comparing highest vs lowest MIND diet tertiles and reported the I2 statistic using R package meta (R Project for Statistical Computing).43 According to the Cochrane Handbook, an I2 statistic of 40% or less indicates minor heterogeneity, an I2 value in the range of 30% to 60% represents moderate heterogeneity, an I2 value in the range of 50% to 90% represents substantial heterogeneity; and an I2 value greater than 75% represents considerable heterogeneity.44 Publication bias was tested by using the Egger test.

Statistical Analyses

In the primary analyses, we assessed the association of MIND diet score and its components (average levels for repeated assessments) with incident dementia using Cox proportional hazard models, with adjustments for age, sex, total energy intake, education level, occupational class (only in WII), household income (only in HRS and FOS), frequency of vigorous physical activity, current smoking status, BMI categories, hypertension, diabetes, hypercholesterolemia (only in WII and FOS), stroke, and cardiovascular diseases. We calculated person-time from the study baseline (previously described) to date of incident dementia, death, loss to follow-up, or the end of follow-up, whichever occurred first. We assessed the associations of the MIND diet as a continuous (per 3-point increase) and categorical (tertiles) variable with the risk of dementia in separate models. Linearity assumption was evaluated by comparing the Akaike information criterion of a linear model with a quadratic model. We analyzed each cohort separately and pooled the estimates from the 3 cohorts using random-effects models.45 We performed prespecified stratified analyses by age (<70 years or ≥70 years), sex (female or male), current smoking status (yes or no), and BMI categories (<25.0 or ≥25.0). We tested for potential interactions using likelihood ratio tests.

We conducted several sensitivity analyses to test the robustness of our primary findings. First, we additionally adjusted the models for depression status because depression itself could be a confounding factor related to both dietary pattern and dementia, although it may be an important mediator.46 Second, we reassessed the association using the single baseline MIND score rather than the mean of multiple MIND scores. We excluded participants who developed dementia in the first 5 years of follow-up to further reduce reverse causation. We alternatively used prespecified cutoffs (7 and 9 points) of MIND diet score rather than the distribution-driven cutoffs. We restricted our analyses to participants without baseline stroke to reduce the potential confounding effect of stroke. Furthermore, we reported E values to assess robustness of the estimates to potential unmeasured confounding.47

Two-sided P values less than .05 indicate statistical significance. Statistical analyses were performed using SAS, version 9.4 (SAS Institute). We conducted multiple imputation for missing covariates using PROC MI (SAS Institute).48

Results
Cohort Analyses

In the cohort analyses, we included a total of 18 136 women and men who were free of dementia at baseline, including 8358 participants (mean [SD] age, 62.2 [6.0] years; 5777 male [69.1%]; 2581 female [30.9%]) from WII, 6758 participants (mean [SD] age, 66.5 [10.4] years; 2793 male [41.3%]; 3965 female [58.7%]) from HRS, and 3020 participants (mean [SD] age, 64.2 [9.1] years; 1372 male [45.4%]; 1648 female [54.6%]) from FOS (Table 1). The means (SDs) of baseline MIND diet scores were 8.3 (1.4) in WII, 7.1 (1.9) in HRS, and 8.1 (1.6) in FOS (eTable 3 in Supplement 1).

Over 166 516 person-years, 775 participants (220 of 105 949 person-years in WII, 338 of 28 934 person-years in HRS, and 217 of 31 633 person-years in FOS) developed incident all-cause dementia. In the multivariable-adjusted model (Table 2), the pooled hazard ratios (HRs) were 0.81 (95% CI, 0.67-0.98) for the highest vs lowest tertiles of MIND score and 0.83 (95% CI, 0.72-0.95; P for trend = .01) for every 3-point increment. The estimates showed moderate robustness to potential unmeasured confounders (E value, 1.70; 95% CI, 1.28-2.12). The HRs per 3-point increment were 0.97 (95% CI, 0.72-1.30) in WII, 0.82 (95% CI, 0.68-0.99) in HRS, and 0.76 (95% CI, 0.57-1.00) in FOS (I2 = 0%). Potential contributors included higher consumption of green leafy and other vegetables, berries, nuts, olive oil, and beans and lower consumptions of red meat and products (eTable 4 in Supplement 1). For example, the HRs were 0.70 (95% CI, 0.53-0.91) for nuts (≥6 vs <1 servings per week) and 1.26 (95% CI, 1.02-1.56) for red meat and products (≥7 vs <4 servings per week).

In the subgroup analyses (eTable 5 in Supplement 1), although no significant effect modification was observed (P interactions >.10 for all tests), the MIND diet was not significantly associated with dementia risk among smokers (HR, 1.10; 95% CI, 0.68-1.75), but in nonsmokers, the association was strong and significant (HR, 0.79; 95% CI, 0.68-0.92). The associations did not vary significantly by sex, age, and BMI. For example, the HR was 0.82 (95% CI, 0.65-1.04) for nonoverweight individuals and 0.82 (95% CI, 0.68-0.97) for overweight individuals.

The primary findings persisted in the sensitivity analyses (eTable 6 in Supplement 1). When using alternative cutoffs, the HR for a score of 7.0 to 8.9 was 0.95 (95% CI, 0.80-1.13) and 0.75 (95% CI, 0.60-0.93) for a score of 9.0 to 15.0, compared with MIND score less than 7.0. Using only baseline MIND diet score rather than the mean MIND scores before the baseline, we observed similar associations (HR, 0.79; 95% CI, 0.69-0.91 for each 3-point increment in MIND score). When we further adjusted the models for depressive symptoms, the HR was 0.83 (95% CI, 0.72-0.95). When we excluded incident dementia cases within the first 5 years of follow-up, the pooled HR was 0.83 (95% CI, 0.63-1.09). Similarly, excluding participants with a stroke history, the association remained significant (HR, 0.85; 95% CI, 0.73-0.99).

Meta-analysis

We screened 257 studies and included 11 cohort studies21,26-28 reported in 5 articles (including this study).18,21,26-28 Specifically, we included the 2 largely nonoverlap subcohorts in the Rotterdam Study, and excluded the analyses on MAP by Morris et al18 because it was updated by Vu et al.26 We converted the HRs per SD increment in the Rotterdam Study to HRs comparing means in highest vs lowest tertiles assuming a linear association.49 The characteristics of the included studies were shown in eTables 7 and 8 in Supplement 1.

Pooling 11 risk estimates for 224 049 participants (5279 incident dementia cases) (Figure 2),21,26-28 the HR comparing the highest vs lowest tertile of the MIND diet score was 0.83 (95% CI, 0.76-0.90), and the E value was 1.70 (95% CI, 1.45-1.96). The association showed moderate heterogeneity across studies (I2 = 35%). We did not observe significant publication bias (eFigure in Supplement 1). No single study substantially affected the pooled results (data not shown).

Discussion

In the current investigation of 3 cohort studies, higher adherence to the MIND diet was associated with a lower risk of incident all-cause dementia. The associations were significant in the HRS and FOS but not in WII. We observed consistent associations across major study subgroups. In the meta-analysis, we observed that the MIND diet was associated with lower risk of dementia, although the evidence was moderately heterogeneous.

To date and to our knowledge, only a few cohort studies have examined the association of the MIND diet with dementia risk, although adherence to this diet has been linked to cognitive function and its decline.17,19 In the MAP (median follow-up = 4.5 years), higher MIND diet score was associated with substantially lower risk of incident AD18 (HR, 0.47; 95% CI, 0.29-0.76 comparing extreme tertiles). A recent study in the Netherlands reported a significant protective association of the MIND diet within the first 7 years of follow-up (HR, 0.85; 95% CI, 0.74-0.98 per SD increment), but this association was no longer significant in longer-term follow-up within the same population of baseline 1.21 Based on these previous findings, our observations in 3 well-characterized cohort studies suggest a potentially protective association. Most studies evaluating the link between the MIND diet and other cognitive outcomes (including cognitive function, its decline and incident cognitive impairment) are limited by small sample sizes or short-term follow-up, which may result in reverse causation induced by early behavioral changes resulting from preclinical dementia. Our study provided valuable information with relatively long-term follow-up, but future studies are still warranted to clarify the causal association between the MIND diet and dementia. Meanwhile, to which extent a healthy diet intervention could reduce dementia risk in specific populations and the optimal intervention time window for this intervention remain largely unknown. Currently, a 3-year, multicenter, randomized clinical trial of the MIND diet on cognitive decline is being conducted in US adults, which is expected to provide valuable evidence for dietary strategies in dementia prevention.50

Although the underlying biological mechanism remains unclear, oxidation and inflammation pathways could explain the observed associations. MIND diet emphasizes several food groups associated with brain health, such as green leafy vegetables, olive oil, and berries,50 which were confirmed in this study. These food groups may confer protection against brain aging through their antioxidant and anti-inflammatory properties and inhibition of β amyloid deposition by specific constituents, such as vitamin E,51 folate,12 flavonoids,11 and carotenoids.9 On the contrary, red and processed meat contains N-nitroso compounds, which may induce oxidative stress and inflammation and contribute to the development of dementia.52

Although the MIND diet showed potential to reduce dementia risk, we observed moderate unexplained heterogeneity in the current literature. The differences in education levels, age ranges, and duration of follow-up periods among cohorts may be the underlying reasons. For example, in the WII cohort where participants were relatively better-educated civil workers, a previous analysis found that midlife alternate healthy eating index was not associated with later-life dementia,16 and our results added that the MIND score was not associated with dementia risk. In the Rotterdam Study (baseline 1), the association of the MIND diet with incident dementia was significant in the first 7-year follow-up but was also attenuated to null in the 15.6-year follow-up.21 In addition, differences in adjustments for confounding may contribute to the heterogeneity. Furthermore, the cultural backgrounds in different populations may be an important underlying source of heterogeneity, and the current literature on the MIND diet is largely based on a Western population. Whether this pattern is beneficial for primary prevention of dementia in other populations warrants exploration.

Strengths and Limitations

The strengths of the current study include long-term follow-up in population-based cohort studies with validated approaches to assess dietary intake. Nevertheless, our findings should be interpreted with caution due to some limitations. First, we were unable to specifically assess the association of the MIND diet with subtypes of dementia because of the inconsistent definitions across cohorts. Second, confounding owing to unmeasured food items could still lead to biased estimation of the association of MIND diet with dementia. Because self-reported food consumption may be subject to measurement error and reporting bias, the MIND diet scores may not accurately reflect the actual adherence to the MIND diet. Given the long preclinical stage of dementia, the observational findings may still be subject to reverse causality because cognitive impairment may affect the ability of reporting of diet and adherence to the diet itself. Cohort studies with shorter-term follow-up may be more likely to be influenced by this, such as the HRS. Therefore, our observational findings of this study do not reflect causality. Third, the cohort studies and meta-analysis mainly consisted of a Western population; therefore, our findings may not be generalizable to populations with different cultural and ethnic backgrounds. Furthermore, misclassification of outcome may exist, especially in the cohorts relying on linkage to data with health electronic systems (eg, WII) or algorithms using data from objective cognitive tests rather than clinical diagnosis (eg, HRS). Finally, consumption of some food groups, such as olive oil, may not have been commonly consumed in specific countries at baseline, and further investigations of these food groups are warranted.

Conclusions

In this analysis of 3 cohort studies and a meta-analysis, findings suggest that adherence to the MIND diet was prospectively associated with lower dementia risk, although moderate heterogeneity was observed across studies. Future studies are needed to evaluate and refine the MIND diet in different populations and to identify the optimal intervention time window for dementia prevention.

Back to top
Article Information

Accepted for Publication: February 20, 2023.

Published Online: May 3, 2023. doi:10.1001/jamapsychiatry.2023.0800

Corresponding Author: Changzheng Yuan, ScD, School of Public Health, the Second Affiliated Hospital, Zhejiang University School of Medicine, 866 Yuhangtang Rd, Hangzhou, Zhejiang 310058, China (chy478@zju.edu.cn).

Author Contributions: Mr Chen and Dr Yuan had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Chen, Zheng, Willett, Yuan.

Acquisition, analysis, or interpretation of data: Chen, Dhana, Y. Huang, L. Huang, Tao, Liu, Melo van Lent, Ascherio, Yuan.

Drafting of the manuscript: Chen.

Critical revision of the manuscript for important intellectual content: Dhana, Y. Huang, L. Huang, Tao, Liu, Melo van Lent, Zheng, Ascherio, Willett, Yuan.

Statistical analysis: Chen, Y. Huang.

Obtained funding: Yuan.

Administrative, technical, or material support: Zheng, Willett.

Supervision: Yuan.

Conflict of Interest Disclosures: Dr Dhana reported receiving grants from the National Institute on Aging/National Institutes of Health (paid to institution) and grants from Alzheimer’s Association (paid to institution) outside the submitted work. No other disclosures were reported.

Funding/Support: This work was supported in part by grant AARG-22-928604 from the Alzheimer’s Association (Dr Yuan).

Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Data Sharing Statement: See Supplement 2.

Additional Contributions: We thank all of the participating individuals and staff of the Whitehall II study, the Health and Retirement Study, and the Framingham Heart Study who made the study possible. No financial compensation beyond usual salary was received for the provided contributions.

References
1.
Livingston  G, Huntley  J, Sommerlad  A,  et al.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.   Lancet. 2020;396(10248):413-446. doi:10.1016/S0140-6736(20)30367-6PubMedGoogle ScholarCrossref
2.
GBD 2019 Dementia Forecasting Collaborators.  Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.   Lancet Public Health. 2022;7(2):e105-e125. doi:10.1016/S2468-2667(21)00249-8Google ScholarCrossref
3.
Prince  M, Wimo  A, Guerchet  M, Ali  GC, Wu  YT, Prina  M. World Alzheimer Report 2015—the global impact of dementia: an analysis of prevalence, incidence, cost and trends. Accessed May 16, 2022. https://www.alzint.org/u/WorldAlzheimerReport2015.pdf
4.
Baumgart  M, Snyder  HM, Carrillo  MC, Fazio  S, Kim  H, Johns  H.  Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective.   Alzheimers Dement. 2015;11(6):718-726. doi:10.1016/j.jalz.2015.05.016PubMedGoogle ScholarCrossref
5.
Morris  MC.  Nutrition and risk of dementia: overview and methodological issues.   Ann N Y Acad Sci. 2016;1367(1):31-37. doi:10.1111/nyas.13047PubMedGoogle ScholarCrossref
6.
Cao  L, Tan  L, Wang  HF,  et al.  Dietary patterns and risk of dementia: a systematic review and meta-analysis of cohort studies.   Mol Neurobiol. 2016;53(9):6144-6154. doi:10.1007/s12035-015-9516-4PubMedGoogle ScholarCrossref
7.
van de Rest  O, Berendsen  AA, Haveman-Nies  A, de Groot  LC.  Dietary patterns, cognitive decline, and dementia: a systematic review.   Adv Nutr. 2015;6(2):154-168. doi:10.3945/an.114.007617PubMedGoogle ScholarCrossref
8.
Liu  YH, Gao  X, Na  M, Kris-Etherton  PM, Mitchell  DC, Jensen  GL.  Dietary pattern, diet quality, and dementia: a systematic review and meta-analysis of prospective cohort studies.   J Alzheimers Dis. 2020;78(1):151-168. doi:10.3233/JAD-200499PubMedGoogle ScholarCrossref
9.
Yuan  C, Chen  H, Wang  Y, Schneider  JA, Willett  WC, Morris  MC.  Dietary carotenoids related to risk of incident Alzheimer dementia (AD) and brain AD neuropathology: a community-based cohort of older adults.   Am J Clin Nutr. 2021;113(1):200-208. doi:10.1093/ajcn/nqaa303PubMedGoogle ScholarCrossref
10.
Commenges  D, Scotet  V, Renaud  S, Jacqmin-Gadda  H, Barberger-Gateau  P, Dartigues  JF.  Intake of flavonoids and risk of dementia.   Eur J Epidemiol. 2000;16(4):357-363. doi:10.1023/A:1007614613771PubMedGoogle ScholarCrossref
11.
Cheng  N, Bell  L, Lamport  DJ, Williams  CM.  Dietary flavonoids and human cognition: a meta-analysis.   Mol Nutr Food Res. 2022;66(21):e2100976. doi:10.1002/mnfr.202100976Google ScholarCrossref
12.
Crichton  GE, Bryan  J, Murphy  KJ.  Dietary antioxidants, cognitive function and dementia: a systematic review.   Plant Foods Hum Nutr. 2013;68(3):279-292. doi:10.1007/s11130-013-0370-0PubMedGoogle ScholarCrossref
13.
Wu  S, Ding  Y, Wu  F, Li  R, Hou  J, Mao  P.  Omega-3 fatty acids intake and risks of dementia and Alzheimer’s disease: a meta-analysis.   Neurosci Biobehav Rev. 2015;48:1-9. doi:10.1016/j.neubiorev.2014.11.008PubMedGoogle ScholarCrossref
14.
Bakre  AT, Chen  R, Khutan  R,  et al.  Association between fish consumption and risk of dementia: a new study from China and a systematic literature review and meta-analysis.   Public Health Nutr. 2018;21(10):1921-1932. doi:10.1017/S136898001800037XPubMedGoogle ScholarCrossref
15.
Ran  LS, Liu  WH, Fang  YY,  et al.  Alcohol, coffee, and tea intake and the risk of cognitive deficits: a dose-response meta-analysis.   Epidemiol Psychiatr Sci. 2021;30:e13. doi:10.1017/S2045796020001183PubMedGoogle ScholarCrossref
16.
Akbaraly  TN, Singh-Manoux  A, Dugravot  A, Brunner  EJ, Kivimäki  M, Sabia  S.  Association of midlife diet with subsequent risk for dementia.   JAMA. 2019;321(10):957-968. doi:10.1001/jama.2019.1432PubMedGoogle ScholarCrossref
17.
Morris  MC, Tangney  CC, Wang  Y,  et al.  MIND diet slows cognitive decline with aging.   Alzheimers Dement. 2015;11(9):1015-1022. doi:10.1016/j.jalz.2015.04.011PubMedGoogle ScholarCrossref
18.
Morris  MC, Tangney  CC, Wang  Y, Sacks  FM, Bennett  DA, Aggarwal  NT.  MIND diet associated with reduced incidence of Alzheimer’s disease.   Alzheimers Dement. 2015;11(9):1007-1014. doi:10.1016/j.jalz.2014.11.009PubMedGoogle ScholarCrossref
19.
Berendsen  AM, Kang  JH, Feskens  EJM, de Groot  CPGM, Grodstein  F, van de Rest  O.  Association of long-term adherence to the MIND diet with cognitive function and cognitive decline in American women.   J Nutr Health Aging. 2018;22(2):222-229. doi:10.1007/s12603-017-0909-0PubMedGoogle ScholarCrossref
20.
Hosking  DE, Eramudugolla  R, Cherbuin  N, Anstey  KJ.  MIND not Mediterranean diet related to 12-year incidence of cognitive impairment in an Australian longitudinal cohort study.   Alzheimers Dement. 2019;15(4):581-589. doi:10.1016/j.jalz.2018.12.011PubMedGoogle ScholarCrossref
21.
de Crom  TOE, Mooldijk  SS, Ikram  MK, Ikram  MA, Voortman  T.  MIND diet and the risk of dementia: a population-based study.   Alzheimers Res Ther. 2022;14(1):8. doi:10.1186/s13195-022-00957-1PubMedGoogle ScholarCrossref
22.
Gómez-Pinilla  F.  Brain foods: the effects of nutrients on brain function.   Nat Rev Neurosci. 2008;9(7):568-578. doi:10.1038/nrn2421PubMedGoogle ScholarCrossref
23.
Marmot  M, Brunner  E.  Cohort profile: the Whitehall II study.   Int J Epidemiol. 2005;34(2):251-256. doi:10.1093/ije/dyh372PubMedGoogle ScholarCrossref
24.
Sonnega  A, Faul  JD, Ofstedal  MB, Langa  KM, Phillips  JWR, Weir  DR.  Cohort profile: the Health and Retirement Study (HRS).   Int J Epidemiol. 2014;43(2):576-585. doi:10.1093/ije/dyu067PubMedGoogle ScholarCrossref
25.
Tsao  CW, Vasan  RS.  Cohort profile: the Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology.   Int J Epidemiol. 2015;44(6):1800-1813. doi:10.1093/ije/dyv337PubMedGoogle ScholarCrossref
26.
Vu  THT, Beck  T, Bennett  DA,  et al.  Adherence to MIND diet, genetic susceptibility, and incident dementia in 3 US cohorts.   Nutrients. 2022;14(13):2759. doi:10.3390/nu14132759PubMedGoogle ScholarCrossref
27.
Zhang  J, Cao  X, Li  X,  et al.  Associations of midlife diet quality with incident dementia and brain structure: findings from the UK Biobank Study.   medRxiv. Preprint posted online May 2, 2022. doi:10.1101/2022.05.06.22274696Google Scholar
28.
Thomas  A, Lefèvre-Arbogast  S, Féart  C,  et al.  Association of a MIND diet with brain structure and dementia in a French population.   J Prev Alzheimers Dis. 2022;9(4):655-664. doi:10.14283/jpad.2022.67PubMedGoogle ScholarCrossref
29.
Brunner  E, Stallone  D, Juneja  M, Bingham  S, Marmot  M.  Dietary assessment in Whitehall II: comparison of 7 d diet diary and food-frequency questionnaire and validity against biomarkers.   Br J Nutr. 2001;86(3):405-414. doi:10.1079/BJN2001414PubMedGoogle ScholarCrossref
30.
Juster  FT, Suzman  R.  An overview of the Health and Retirement Study.   J Hum Resour. 1995;30:S7-S56. doi:10.2307/146277Google ScholarCrossref
31.
Bishop  NJ, Wang  K.  Food insecurity, comorbidity, and mobility limitations among older US adults: findings from the Health and Retirement Study and Health Care and Nutrition Study.   Prev Med. 2018;114:180-187. doi:10.1016/j.ypmed.2018.07.001PubMedGoogle ScholarCrossref
32.
Satizabal  CL, Beiser  AS, Chouraki  V, Chêne  G, Dufouil  C, Seshadri  S.  Incidence of dementia over 3 decades in the Framingham Heart Study.   N Engl J Med. 2016;374(6):523-532. doi:10.1056/NEJMoa1504327PubMedGoogle ScholarCrossref
33.
Pase  MP, Himali  JJ, Beiser  AS,  et al.  Sugar- and artificially sweetened beverages and the risks of incident stroke and dementia: a prospective cohort study.   Stroke. 2017;48(5):1139-1146. doi:10.1161/STROKEAHA.116.016027PubMedGoogle ScholarCrossref
34.
von Elm  E, Altman  DG, Egger  M, Pocock  SJ, Gøtzsche  PC, Vandenbroucke  JP; STROBE Initiative.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.   Ann Intern Med. 2007;147(8):573-577. doi:10.7326/0003-4819-147-8-200710160-00010PubMedGoogle ScholarCrossref
35.
Willett  WC, Sampson  L, Stampfer  MJ,  et al.  Reproducibility and validity of a semiquantitative food frequency questionnaire.   Am J Epidemiol. 1985;122(1):51-65. doi:10.1093/oxfordjournals.aje.a114086PubMedGoogle ScholarCrossref
36.
Yuan  C, Spiegelman  D, Rimm  EB,  et al.  Validity of a dietary questionnaire assessed by comparison with multiple weighed dietary records or 24-hour recalls.   Am J Epidemiol. 2017;185(7):570-584. doi:10.1093/aje/kww104PubMedGoogle ScholarCrossref
37.
Yuan  C, Spiegelman  D, Rimm  EB,  et al.  Relative validity of nutrient intakes assessed by questionnaire, 24-hour recalls, and diet records as compared with urinary recovery and plasma concentration biomarkers: findings for women.   Am J Epidemiol. 2018;187(5):1051-1063. doi:10.1093/aje/kwx328PubMedGoogle ScholarCrossref
38.
Al-Shaar  L, Yuan  C, Rosner  B,  et al.  Reproducibility and validity of a semiquantitative food frequency questionnaire in men assessed by multiple methods.   Am J Epidemiol. 2021;190(6):1122-1132. doi:10.1093/aje/kwaa280PubMedGoogle ScholarCrossref
39.
Yue  Y, Yuan  C, Wang  DD,  et al.  Reproducibility and validity of diet quality scores derived from food-frequency questionnaires.   Am J Clin Nutr. 2022;115(3):843-853. doi:10.1093/ajcn/nqab368PubMedGoogle ScholarCrossref
40.
Crimmins  EM, Kim  JK, Langa  KM, Weir  DR.  Assessment of cognition using surveys and neuropsychological assessment: the Health and Retirement Study and the Aging, Demographics, and Memory Study.   J Gerontol B Psychol Sci Soc Sci. 2011;66 suppl 1(suppl 1):i162-i171. doi:10.1093/geronb/gbr048Google ScholarCrossref
41.
Moher  D, Liberati  A, Tetzlaff  J, Altman  DG; PRISMA Group.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.   PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097PubMedGoogle ScholarCrossref
42.
Mediterranean–Dietary Approaches to Stop Hypertension (MIND) diet and risk of dementia: meta-analysis of cohort studies. INPLASY:INPLASY202270127. Published online July 31, 2022. https://inplasy.com/inplasy-2022-7-0127/
43.
Schwarzer  G.  meta: an R package for meta-analysis.   R News. 2007;7(3):40-45.Google Scholar
44.
Higgins  JPT, Thomas  J, Chandler  J,  et al, eds.  Cochrane Handbook for Systematic Reviews of Interventions. 2nd ed. John Wiley & Sons; 2019.
45.
Riley  RD, Lambert  PC, Abo-Zaid  G.  Meta-analysis of individual participant data: rationale, conduct, and reporting.   BMJ. 2010;340:c221. doi:10.1136/bmj.c221PubMedGoogle ScholarCrossref
46.
Byers  AL, Yaffe  K.  Depression and risk of developing dementia.   Nat Rev Neurol. 2011;7(6):323-331. doi:10.1038/nrneurol.2011.60PubMedGoogle ScholarCrossref
47.
VanderWeele  TJ, Ding  P.  Sensitivity analysis in observational research: introducing the E-value.   Ann Intern Med. 2017;167(4):268-274. doi:10.7326/M16-2607PubMedGoogle ScholarCrossref
48.
Schafer  JL.  Multiple imputation: a primer.   Stat Methods Med Res. 1999;8(1):3-15. doi:10.1177/096228029900800102PubMedGoogle ScholarCrossref
49.
Chêne  G, Thompson  SG.  Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form.   Am J Epidemiol. 1996;144(6):610-621. doi:10.1093/oxfordjournals.aje.a008971PubMedGoogle ScholarCrossref
50.
Liu  X, Morris  MC, Dhana  K,  et al.  Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) study: rationale, design and baseline characteristics of a randomized control trial of the MIND diet on cognitive decline.   Contemp Clin Trials. 2021;102:106270. doi:10.1016/j.cct.2021.106270PubMedGoogle ScholarCrossref
51.
McCleery  J, Abraham  RP, Denton  DA,  et al.  Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.   Cochrane Database Syst Rev. 2018;11(11):CD011905. doi:10.1002/14651858.CD011905.pub2PubMedGoogle ScholarCrossref
52.
de la Monte  SM, Neusner  A, Chu  J, Lawton  M.  Epidemiological trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer’s disease, diabetes mellitus, and non-alcoholic steatohepatitis.   J Alzheimers Dis. 2009;17(3):519-529. doi:10.3233/JAD-2009-1070PubMedGoogle ScholarCrossref
×